title: HLA-target antigens and T-cell receptor diversity of activated T cells invading the skin during acute graft-versus-host disease.
abstract: To study the repertoire and specificity of T lymphocytes infiltrating skin lesions during graft-versus-host disease (GVHD), we performed an exhaustive molecular and functional analysis of 146 T-cell clones derived from the skin of three patients undergoing an acute GVHD after allogeneic bone marrow transplantation (BMT) from HLA-mismatched related donors. Analysis of T-cell receptor (TCR) rearrangement and TCR chain junctional sequences demonstrated the presence of 11 distinct clones among the 64 derived from patient UPN1, six among the 58 derived from patient UPN2, and seven among the 24 derived from patient UPN3. Three of the 11 T-cell clones from patient UPN1, and all clones from patients UPN2 and UPN3 reacted with mismatched HLA alleles between the bone-marrow donor and recipient. Moreover, both HLA class I (HLA-A2 and -B27) and class II (HLA DP101, DP401, DP1301, DQ8, and DR402) molecules were recognized during this early antihost response. Finally, both TCR alpha and beta chains turned out to be extremely diverse, even within populations of clones derived from the same patient and directed against the same HLA allele. Taken together, these results indicate that any HLA mismatch is potentially targeted during early GVHD, and that the T-cell response at the onset of GVHD is both oligoclonal and highly diversified.
authors.affiliation: Institut National de la Santé et de la Recherche Médicale (Unité 211), Nantes, France.
authors.forename: J
authors.initials: J
authors.lastname: Gaschet
authors.forename: M A
authors.initials: MA
authors.lastname: Treviño
authors.forename: M
authors.initials: M
authors.lastname: Cherel
authors.forename: R
authors.initials: R
authors.lastname: Vivien
authors.forename: A
authors.initials: A
authors.lastname: Garcia-Sahuquillo
authors.forename: M M
authors.initials: MM
authors.lastname: Hallet
authors.forename: M
authors.initials: M
authors.lastname: Bonneville
authors.forename: J L
authors.initials: JL
authors.lastname: Harrousseau
authors.forename: R
authors.initials: R
authors.lastname: Bragado
authors.forename: N
authors.initials: N
authors.lastname: Milpied
authors.forename: H
authors.initials: H
authors.lastname: Vié
mesh_terms: D000208:Acute Disease; D000595:Amino Acid Sequence; D001402:B-Lymphocytes / Q000276:immunology / Q000473:pathology; D001706:Biopsy; D016026:Bone Marrow Transplantation / Q000276:immunology; D002461:Cell Line, Transformed; D002648:Child; D002999:Clone Cells / Q000276:immunology; D003602:Cytotoxicity, Immunologic; D017809:Fatal Outcome; D005260:Female; D015329:Gene Rearrangement, T-Lymphocyte; D006086:Graft vs Host Disease / Q000276:immunology* / Q000473:pathology; D006680:HLA Antigens / Q000276:immunology*; D004854:Herpesvirus 4, Human; D006648:Histocompatibility; D006801:Humans; D008297:Male; D008969:Molecular Sequence Data; D011948:Receptors, Antigen, T-Cell / Q000235:genetics*; D012867:Skin / Q000276:immunology* / Q000473:pathology; D016176:T-Lymphocyte Subsets / Q000276:immunology* / Q000473:pathology; D014184:Transplantation, Homologous / Q000276:immunology
chemical_list: D006680:HLA Antigens; D011948:Receptors, Antigen, T-Cell